Maria de la Cruz
Family · Kissimmee, FLNPI 1417428095
Payments from drug & device makers
Across 87 payments — averaging $25.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$778
- AstraZeneca$272
- Boehringer Ingelheim$139
- Biogen$106
- Neurocrine Biosciences, Inc.$93
- Amgen$92
- plus $728 from 19 others
What the payments were for
- Food & beverage$2,19799%
- Education$121%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 29 | $778 |
| AstraZeneca | 4 | $272 |
| Boehringer Ingelheim | 3 | $139 |
| Biogen | 5 | $106 |
| Neurocrine Biosciences, Inc. | 5 | $93 |
| Amgen | 4 | $92 |
| Johnson & Johnson | 4 | $90 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $76 |
| Lilly USA, LLC | 4 | $70 |
| E.r. Squibb & Sons, L.L.C. | 3 | $64 |
| Sanofi | 3 | $55 |
| Alkermes, Inc. | 3 | $51 |
| Teva Pharmaceuticals USA, Inc. | 3 | $47 |
| Novo Nordisk | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| EMD Serono, Inc. | 1 | $25 |
| Noven Therapeutics, LLC | 1 | $23 |
| Acadia Pharmaceuticals Inc | 1 | $22 |
| Ironshore Pharmaceuticals Inc. | 1 | $20 |
| Luye Pharma (USA) Ltd. | 1 | $20 |
| Biohaven Pharmaceuticals, Inc. | 1 | $19 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Amarin Pharma, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,209 in reported general payments places this provider in the 80th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Quetiapine Fumarate | 20 | $547 |
| Mirtazapine | 19 | $355 |
| Trazodone Hcl | 16 | $347 |
| Hydroxyzine Hcl | 11 | $301 |
| Hydroxyzine Pamoate | 11 | $146 |
| Amlodipine Besylate | 22 | $133 |
| Paroxetine Hcl | 13 | $78 |
| Atorvastatin Calcium | 12 | $74 |
| Sertraline Hcl | 12 | $52 |
| Losartan Potassium | 11 | $49 |
Paid to pharmacies, not to this prescriber.
Other family in Kissimmee
- John HuffakerVenice$8M
- Stephanie MompointMiami$4.5M
- Miguel TrujilloMiami Gardens$4.4M
- Itsel Cardenas RamonMiami$1M
- Lewis HarringtonTampa$954K
- Adam StrosbergFort Lauderdale$859K
- Danielle PharesFt Lauderdale$713K
- David RodriguezHialeah$658K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.